Association of the CC genotype of the regulatory BCL2 promoter polymorphism (− 938C> A) with better 2-year survival in patients with glioblastoma multiforme
N El Hindy, HS Bachmann, N Lambertz… - Journal of …, 2011 - thejns.org
Object Bcl-2 plays a key role in the downregulation of apoptosis and proliferation and leads
to increased chemoresistance in glioblastoma multiforme (GBM). The authors investigated …
to increased chemoresistance in glioblastoma multiforme (GBM). The authors investigated …
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C> A) with better 2-year survival in patients with glioblastoma multiforme.
N El Hindy, HS Bachmann, N Lambertz… - Journal of …, 2011 - europepmc.org
Methods Data from 160 patients suffering from GBM were retrospectively evaluated. Study
inclusion criteria consisted of available DNA and, in patients still alive, a follow-up of at least …
inclusion criteria consisted of available DNA and, in patients still alive, a follow-up of at least …
[引用][C] Association of the CC genotype of the regulatory BCL2 promoter polymorphism (―938C> A) with better 2-year survival in patients with glioblastoma multiforme
N EL HINDY, HS BACHMANN… - Journal of …, 2011 - pascal-francis.inist.fr
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (―938C>A)
with better 2-year survival in patients with glioblastoma multiforme: Clinical article CNRS …
with better 2-year survival in patients with glioblastoma multiforme: Clinical article CNRS …
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C> A) with better 2-year survival in patients with glioblastoma multiforme
N El Hindy, HS Bachmann… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Object Bcl-2 plays a key role in the downregulation of apoptosis and proliferation and leads
to increased chemoresistance in glioblastoma multiforme (GBM). The authors investigated …
to increased chemoresistance in glioblastoma multiforme (GBM). The authors investigated …